Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Matyas

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Bioconjugate Chemistry|December 19, 2023
Enhancing Protective Antibodies against Opioids through Antigen Display on Virus-like ParticlesFatemeh Shafieichaharberoud, Shuyao Lang, Connor Whalen, et al.
Organic & Biomolecular Chemistry|July 5, 2014
Synthesis and immunological effects of heroin vaccinesFuying Li, Kejun Cheng, Joshua F G Antoline, et al.
NPJ Vaccines|January 28, 2022
Restricted valency (NPNA)<sub>n</sub> repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparumMark D Langowski, Farhat A Khan, Sofya Savransky, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2020
Optimization of a <i>Plasmodium falciparum</i> circumsporozoite protein repeat vaccine using the tobacco mosaic virus platformMark D Langowski, Farhat A Khan, Alexis A Bitzer, et al.
Msphere|May 3, 2019
Enhanced Immunogenicity and Protective Efficacy of a <i>Campylobacter jejuni</i> Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21Amritha Ramakrishnan, Nina M Schumack, Christina L Gariepy, et al.
Molecules (Basel, Switzerland)|March 10, 2022
Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin VaccinesAgnieszka Sulima, Fuying Li, Jeffrey Brian Morgan, et al.
Msphere|May 24, 2019
Correction for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21"Amritha Ramakrishnan, Nina M Schumack, Christina L Gariepy, et al.
Msphere|June 28, 2019
Erratum for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21"Amritha Ramakrishnan, Nina M Schumack, Christina L Gariepy, et al.
Vaccine|October 13, 2025
Immunogenicity of HLA-restricted peptide vaccine candidates delivered by self-assembling protein nanoparticle (SAPN) technologyMaria Belmonte, Kwadwo Asamoah Kusi, Eric Kyei-Baafour, et al.
HLA|June 26, 2026
Full-Length Next-Generation Sequencing of 11 HLA Loci of More Than 1000 Individuals From Clinical Cohorts in East and West AfricaYvonne V Rosario, Aviva Geretz, Lakshmi Rani Iyer, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Bioconjugate Chemistry|December 19, 2023
Enhancing Protective Antibodies against Opioids through Antigen Display on Virus-like ParticlesFatemeh Shafieichaharberoud, Shuyao Lang, Connor Whalen, et al.
Organic & Biomolecular Chemistry|July 5, 2014
Synthesis and immunological effects of heroin vaccinesFuying Li, Kejun Cheng, Joshua F G Antoline, et al.
NPJ Vaccines|January 28, 2022
Restricted valency (NPNA)<sub>n</sub> repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparumMark D Langowski, Farhat A Khan, Sofya Savransky, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2020
Optimization of a <i>Plasmodium falciparum</i> circumsporozoite protein repeat vaccine using the tobacco mosaic virus platformMark D Langowski, Farhat A Khan, Alexis A Bitzer, et al.
Msphere|May 3, 2019
Enhanced Immunogenicity and Protective Efficacy of a <i>Campylobacter jejuni</i> Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21Amritha Ramakrishnan, Nina M Schumack, Christina L Gariepy, et al.
Molecules (Basel, Switzerland)|March 10, 2022
Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin VaccinesAgnieszka Sulima, Fuying Li, Jeffrey Brian Morgan, et al.
Msphere|May 24, 2019
Correction for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21"Amritha Ramakrishnan, Nina M Schumack, Christina L Gariepy, et al.
Msphere|June 28, 2019
Erratum for Ramakrishnan et al., "Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21"Amritha Ramakrishnan, Nina M Schumack, Christina L Gariepy, et al.
Vaccine|October 13, 2025
Immunogenicity of HLA-restricted peptide vaccine candidates delivered by self-assembling protein nanoparticle (SAPN) technologyMaria Belmonte, Kwadwo Asamoah Kusi, Eric Kyei-Baafour, et al.
HLA|June 26, 2026
Full-Length Next-Generation Sequencing of 11 HLA Loci of More Than 1000 Individuals From Clinical Cohorts in East and West AfricaYvonne V Rosario, Aviva Geretz, Lakshmi Rani Iyer, et al.
Pageof 12